Favourable outcome in retinal macrovessel-related choroidal neovascularization

Area of Science:

• Ophthalmology
• Vascular Biology
• Retinal Imaging

Background:

• Congenital retinal macrovessel (CRM) is a rare vascular anomaly characterized by an aberrant retinal vessel crossing the macula.
• CRMs are typically asymptomatic and discovered incidentally during funduscopic examinations.
• This condition involves abnormal blood vessel development within the retina.

Observation:

• This report details a unique case of a venous CRM.
• The patient presented with visual impairment attributed to the development of a choroidal nonvascular membrane (CNV).
• The aberrant vessel's anatomical characteristics and its association with CNV were noted.

Findings:

• Intravitreal injection of aflibercept was administered as a treatment for the CNV.
• The treatment led to a significant improvement in the patient's visual acuity.
• Anatomical assessment confirmed a favorable outcome with resolution of the CNV.

Implications:

• This case highlights a potential complication of CRM, namely CNV-induced visual impairment.
• Intravitreal aflibercept demonstrates efficacy in managing CNV associated with CRM.
• Further research may explore the long-term outcomes and optimal management strategies for CRM-related complications.